APO RESEARCH · REPORT
Epinephrine
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
Product & engineering
Understand the product.
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
As a medication it is used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding. In this report, we mainly focus on the Epinephrine Auto-injector and Epinephrine Prefilled Syringe.
Selected research
Industry Growth & Trends
Global Epinephrine Industry Growth and Trends Forecast to 2032
Market perspective
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
As a medication it is used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding. In this report, we mainly focus on the Epinephrine Auto-injector and Epinephrine Prefilled Syringe.
Global Epinephrine key players include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, etc. Global top five manufacturers hold a share about 60%. USA is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Epinephrine Auto-injector is the largest segment, with a share about 60%. And in terms of application, the largest application is Anaphylaxis, followed by Cardiac Arrest, etc.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Epinephrine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Epinephrine market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Epinephrine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Epinephrine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Epinephrine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Epinephrine Market by Company
Mylan Inc
Impax
ALK Abello
Lincoln Medical
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao
Epinephrine Segment by Type
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Epinephrine Segment by Application
Anaphylaxis
Cardiac Arrest
Others
Epinephrine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epinephrine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epinephrine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epinephrine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epinephrine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Epinephrine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Epinephrine Auto-injector
- Epinephrine Prefilled Syringe
- Combination Epinephrine Products
Applications
- Anaphylaxis
- Cardiac Arrest
- Others
Companies covered
- Mylan Inc
- Impax
- ALK Abello
- Lincoln Medical
- Pfizer
- Amphastar
- Emerade
- Grand Pharma
- Harvest Pharmaceuticals
- Merit Pharmaceutical
- Tianjin Jinyao
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Epinephrine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Epinephrine Sales Estimates and Forecasts (2021-2032)
- 1.3 Epinephrine Market by Type
- 1.3.1 Epinephrine Auto-injector
- 1.3.2 Epinephrine Prefilled Syringe
- 1.3.3 Combination Epinephrine Products
- 1.4 Global Epinephrine Market Size by Type
- 1.4.1 Global Epinephrine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Epinephrine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Epinephrine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Epinephrine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Epinephrine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Epinephrine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Epinephrine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Epinephrine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Epinephrine Industry Trends
- 2.2 Epinephrine Industry Drivers
- 2.3 Epinephrine Industry Opportunities and Challenges
- 2.4 Epinephrine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Epinephrine Revenue (2021-2026)
- 3.2 Global Top Players by Epinephrine Sales (2021-2026)
- 3.3 Global Top Players by Epinephrine Price (2021-2026)
- 3.4 Global Epinephrine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Epinephrine Major Company Production Sites & Headquarters
- 3.6 Global Epinephrine Company, Product Type & Application
- 3.7 Global Epinephrine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Epinephrine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Epinephrine Players Market Share by Revenue in 2025
- 3.8.3 2025 Epinephrine Tier 1, Tier 2, and Tier 3
4 Epinephrine Regional Status and Outlook
- 4.1 Global Epinephrine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Epinephrine Historic Market Size by Region
- 4.2.1 Global Epinephrine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Epinephrine Sales in Value by Region (2021-2026)
- 4.2.3 Global Epinephrine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Epinephrine Forecasted Market Size by Region
- 4.3.1 Global Epinephrine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Epinephrine Sales in Value by Region (2027-2032)
- 4.3.3 Global Epinephrine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Epinephrine by Application
- 5.1 Epinephrine Market by Application
- 5.1.1 Anaphylaxis
- 5.1.2 Cardiac Arrest
- 5.1.3 Others
- 5.2 Global Epinephrine Market Size by Application
- 5.2.1 Global Epinephrine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Epinephrine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Epinephrine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Epinephrine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Epinephrine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Epinephrine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Epinephrine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Epinephrine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Mylan Inc
- 6.1.1 Mylan Inc Company Information
- 6.1.2 Mylan Inc Business Overview
- 6.1.3 Mylan Inc Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Mylan Inc Epinephrine Product Portfolio
- 6.1.5 Mylan Inc Recent Developments
- 6.2 Impax
- 6.2.1 Impax Company Information
- 6.2.2 Impax Business Overview
- 6.2.3 Impax Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Impax Epinephrine Product Portfolio
- 6.2.5 Impax Recent Developments
- 6.3 ALK Abello
- 6.3.1 ALK Abello Company Information
- 6.3.2 ALK Abello Business Overview
- 6.3.3 ALK Abello Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 ALK Abello Epinephrine Product Portfolio
- 6.3.5 ALK Abello Recent Developments
- 6.4 Lincoln Medical
- 6.4.1 Lincoln Medical Company Information
- 6.4.2 Lincoln Medical Business Overview
- 6.4.3 Lincoln Medical Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Lincoln Medical Epinephrine Product Portfolio
- 6.4.5 Lincoln Medical Recent Developments
- 6.5 Pfizer
- 6.5.1 Pfizer Company Information
- 6.5.2 Pfizer Business Overview
- 6.5.3 Pfizer Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Pfizer Epinephrine Product Portfolio
- 6.5.5 Pfizer Recent Developments
- 6.6 Amphastar
- 6.6.1 Amphastar Company Information
- 6.6.2 Amphastar Business Overview
- 6.6.3 Amphastar Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Amphastar Epinephrine Product Portfolio
- 6.6.5 Amphastar Recent Developments
- 6.7 Emerade
- 6.7.1 Emerade Company Information
- 6.7.2 Emerade Business Overview
- 6.7.3 Emerade Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Emerade Epinephrine Product Portfolio
- 6.7.5 Emerade Recent Developments
- 6.8 Grand Pharma
- 6.8.1 Grand Pharma Company Information
- 6.8.2 Grand Pharma Business Overview
- 6.8.3 Grand Pharma Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Grand Pharma Epinephrine Product Portfolio
- 6.8.5 Grand Pharma Recent Developments
- 6.9 Harvest Pharmaceuticals
- 6.9.1 Harvest Pharmaceuticals Company Information
- 6.9.2 Harvest Pharmaceuticals Business Overview
- 6.9.3 Harvest Pharmaceuticals Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Harvest Pharmaceuticals Epinephrine Product Portfolio
- 6.9.5 Harvest Pharmaceuticals Recent Developments
- 6.10 Merit Pharmaceutical
- 6.10.1 Merit Pharmaceutical Company Information
- 6.10.2 Merit Pharmaceutical Business Overview
- 6.10.3 Merit Pharmaceutical Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Merit Pharmaceutical Epinephrine Product Portfolio
- 6.10.5 Merit Pharmaceutical Recent Developments
- 6.11 Tianjin Jinyao
- 6.11.1 Tianjin Jinyao Company Information
- 6.11.2 Tianjin Jinyao Business Overview
- 6.11.3 Tianjin Jinyao Epinephrine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Tianjin Jinyao Epinephrine Product Portfolio
- 6.11.5 Tianjin Jinyao Recent Developments
7 North America by Country
- 7.1 North America Epinephrine Sales by Country
- 7.1.1 North America Epinephrine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Epinephrine Sales by Country (2021-2026)
- 7.1.3 North America Epinephrine Sales Forecast by Country (2027-2032)
- 7.2 North America Epinephrine Market Size by Country
- 7.2.1 North America Epinephrine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Epinephrine Market Size by Country (2021-2026)
- 7.2.3 North America Epinephrine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Epinephrine Sales by Country
- 8.1.1 Europe Epinephrine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Epinephrine Sales by Country (2021-2026)
- 8.1.3 Europe Epinephrine Sales Forecast by Country (2027-2032)
- 8.2 Europe Epinephrine Market Size by Country
- 8.2.1 Europe Epinephrine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Epinephrine Market Size by Country (2021-2026)
- 8.2.3 Europe Epinephrine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Epinephrine Sales by Country
- 9.1.1 Asia-Pacific Epinephrine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Epinephrine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Epinephrine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Epinephrine Market Size by Country
- 9.2.1 Asia-Pacific Epinephrine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Epinephrine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Epinephrine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Epinephrine Sales by Country
- 10.1.1 South America Epinephrine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Epinephrine Sales by Country (2021-2026)
- 10.1.3 South America Epinephrine Sales Forecast by Country (2027-2032)
- 10.2 South America Epinephrine Market Size by Country
- 10.2.1 South America Epinephrine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Epinephrine Market Size by Country (2021-2026)
- 10.2.3 South America Epinephrine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Epinephrine Sales by Country
- 11.1.1 Middle East and Africa Epinephrine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Epinephrine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Epinephrine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Epinephrine Market Size by Country
- 11.2.1 Middle East and Africa Epinephrine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Epinephrine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Epinephrine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Epinephrine Value Chain Analysis
- 12.1.1 Epinephrine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Epinephrine Production Mode & Process
- 12.2 Epinephrine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Epinephrine Distributors
- 12.2.3 Epinephrine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst